A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

OBJECTIVES: Invasive pneumococcal disease (IPD), pneumonia and acute otitis media (AOM) still represent a significant medical burden in children < 5 years of age in New Zealand (NZ), with marked disparities across socio-economic and ethnic groups. This cost-effectiveness evaluation aims to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Lijoy, Talbot, Louise, Govender, Andrea, Zhang, Xu-Hao, Mungall, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940727/
https://www.ncbi.nlm.nih.gov/pubmed/29633160
http://dx.doi.org/10.1007/s40258-018-0387-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940727/
https://www.ncbi.nlm.nih.gov/pubmed/29633160
http://dx.doi.org/10.1007/s40258-018-0387-5

Ejemplares similares